Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Advisor
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Adelaide Research & Scholarship
Adelaide Research & Scholarship
Search
Search:
All collections
Schools and Disciplines
School of Medicine
Medicine
Medicine publications
for
Current filters:
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Start a new search
Add filters:
Use filters to refine the search results.
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Results 21-30 of 41 (Search time: 0.006 seconds).
previous
1
2
3
4
5
next
Item hits:
Preview
Issue Date
Title
Author(s)
2013
Low GFI1 expression in white blood cells of CP-CML patients at diagnosis is strongly associated with subsequent blastic transformation
Kok, C.
;
Watkins, D.
;
Leclercq, T.
;
D'Andrea, R.
;
Hughes, T.
;
White, D.
2010
Blocking cytokine signaling along with intense Bcr-Abl kinase inhibition induces apoptosis in primary CML progenitors
Hiwase, D.
;
White, D.
;
Powell, J.
;
Saunders, V.
;
Zrim, S.
;
Frede, A.
;
Guthridge, M.
;
Lopez, A.
;
D'Andrea, R.
;
To, L.
;
Vaz de Melo, J.
;
Kumar, S.
;
Hughes, T.
2010
The poor response to imatinib observed in CML patients with low OCT-1 activity is not attributable to lower uptake of imatinib into their CD34⁺ cells
Engler, J.
;
Frede, A.
;
Saunders, V.
;
Zannettino, A.
;
White, D.
;
Hughes, T.
2010
Plasma adiponectin levels are markedly elevated in imatinib-treated chronic myeloid leukemia (CML) patients: A mechanism for improved insulin sensitivity in Type 2 diabetic CML patients?
Fitter, S.
;
Vandyke, K.
;
Schultz, C.
;
White, D.
;
Hughes, T.
;
Zannettino, A.
2012
Classification of patients with chronic myeloid leukemia on basis of BCR-ABL transcript level at 3 months fails to identify patients with low organic cation transporter-1 activity destined to have poor imatinib response
White, D.
;
Hughes, T.
2010
Functional activity of the OCT-1 protein is predictive of long-term outcome in patients with chronic-phase chronic myeloid leukemia treated with Imatinib
White, D.
;
Dang, P.
;
Engler, J.
;
Frede, A.
;
Osborn, M.
;
Saunders, V.
;
Manley, P.
;
Zrim, S.
;
Hughes, T.
2011
SHP-1 expression accounts for resistance to imatinib treatment in Philadelphia chromosome-positive cells derived from patients with chronic myeloid leukemia
Esposito, N.
;
Colavita, I.
;
Quintarelli, C.
;
Sica, A.
;
Peluso, A.
;
Luciano, L.
;
Picardi, M.
;
Vecchio, L.
;
Buonomo, T.
;
Hughes, T.
;
White, D.
;
Radich, J.
;
Russo, D.
;
Branford, S.
;
Saglio, G.
;
Vaz de Melo, J.
;
Martinelli, R.
;
Ruoppolo, M.
;
Kalebic, T.
;
Martinelli, G.
;
et al.
2013
Clarithromycin enhances dasatinib-induced cell death in chronic myeloid leukemia cells, by inhibition of late stage autophagy
Schafranek, L.
;
Leclercq, T.
;
White, D.
;
Hughes, T.
2011
OCT-1 function varies with cell lineage but is not influenced by BCR-ABL
Engler, J.
;
Zannettino, A.
;
Bailey, C.
;
Rasko, J.
;
Hughes, T.
;
White, D.
2013
Dasatinib targets chronic myeloid leukemia-CD34⁺ progenitors as effectively as it targets mature cells
Hiwase, D.
;
Saunders, V.
;
Nievergall, E.
;
Ross, D.
;
White, D.
;
Hughes, T.
Discover
Author
12
Saunders, V.
9
Hiwase, D.
9
Yeung, D.
8
Kok, C.
7
Dang, P.
6
Branford, S.
6
Eadie, L.
6
Frede, A.
5
Engler, J.
5
Leclercq, T.
.
next >
Subject
22
Humans
18
Leukemia, Myelogenous, Chronic, B...
16
Pyrimidines
11
Imatinib Mesylate
11
Protein Kinase Inhibitors
10
Antineoplastic Agents
10
Piperazines
9
Benzamides
9
Female
9
Male
.
next >
Date issued
3
2018
6
2017
4
2016
2
2015
2
2014
10
2013
3
2012
4
2011
7
2010